Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
AliveCor
AliveCorAliveCor Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Where is AliveCor actually being used routinely?
Still openWhether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Public evidence
AliveCor Secures CE Mark for Kardia 12L AI-Powered ECG System in Europe
HIT Consultant
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 1 public external signal(s) across 1 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands AliveCor through a published study, deployment evidence, company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand AliveCor. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
KardiaMobile 6L is a portable device that records six-lead ECGs using a smartphone. It provides automated analysis to help identify heart rhythms like atrial fibrillation, bradycardia, and tachycardia.According to AliveCor
What AliveCor states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The device captures a six-lead ECG for remote review and analysis of heart rhythms.
According to AliveCor
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
AliveCor Secures CE Mark for Kardia 12L AI-Powered ECG System in Europe
According to HIT Consultant
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
- Product Overview: KardiaMobile 6L is a portable, six-lead electrocardiogram (ECG) device designed for both personal and clinical use. It enables users to record a 30-second ECG and receive instant analysis of various cardiac conditions, including atrial fibrillation (AFib), bradycardia, tachycardia, and normal…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Key strength
Evidence level: peer reviewed
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of AliveCor accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence
Related technologies